PDMP & Opioid Abuse News

PDMP & Opioid Abuse News
- NDLEA to partner NCWS to check drug abuse among women 16 May 2022 15:48 News Diary Online The National Drug Law Enforcement Agency (NDLEA) on Monday promised to partner the National Council for Women Societies (NCWS) to address drug abuse among women. The Chairman/Chief Executive of NDLEA, Brig.-Gen. Buba Marwa (rtd), made the promise when …
- Acutis Diagnostics in Hicksville Advances Testing for Covid, Opioids, Cancer 16 May 2022 13:04 Long Island Press - New York Sign up for our COVID-19 newsletter to stay up-to-date on the latest coronavirus news throughout New York Acutis Diagnostics, a specialized clinical and biosciences company, has been tackling some of Long Island’s most pressing healthcare issues with …
- CareSTL Health plans to offer alternatives to opioids, housing in the Greater Ville 15 May 2022 11:22 St. Louis Public Radio - Missouri CareSTL Health plans to open a health care clinic and provide low-income and senior housing for residents of the Greater Ville neighborhood. The $25 million Ville Wellness Campus, to open next year, will focus on physical, occupational and behavioral …
- India News | Drug Abuse Bigger Challenge, It Funds Terror Networks: J-K Police Chief 14 May 2022 18:08 Latestly Srinagar, May 14 (PTI) Drug abuse is a big challenge as it not only provides oxygen to terrorism by means of funding terror networks but also targets the younger generation, Jammu and Kashmir police chief Dilbag Singh said on Saturday. Singh, the Director- …
- ASUU strike spiraling up drug abuse in Edo, Obaseki cries… 14 May 2022 07:46 The Cable Godwin Obaseki, Edo governor, has warned that the continued strike by the Academic Staff Union of Universities (ASUU) is causing a spike in the rate of drug abuse in the state. The governor spoke after a review of the state’s security situation for the …
- ASUU strike has worsened drug abuse – Gov. Obaseki 13 May 2022 20:46 Nigeria News Today Edo’s Gov. Godwin Obaseki on Friday in Benin blamed increasing rate of drug abuse in the state on the lingering Academic Staff Union of Universities’ (ASUU) strike. Reviewing the state’s security situation for the months of February, March and April, Gov. …
- Computer Science student wins award for research into drug abuse detection online 13 May 2022 15:35 Oklahoma State University Friday, May 13, 2022 Media Contact: Jordan Bishop | Editor, Department of Brand Management | 405-744-7193 | jordan.bishop@okstate.edu The Oklahoma State University Coalition for the Advancement of Digital Research and Education (CADRE) recently partnered …
- Black leaders address opioid crisis, drug abuse stigma in central Ohio 13 May 2022 03:50 NBC 4 - Ohio COLUMBUS, Ohio (WCMH) — Black community leaders are drawing attention to the growing opioid crisis in Franklin County. Through an event called “Opioid Community Conversation,” dozens of residents and leaders joined together for a meeting around opioid …
- ‘Operation Candy Man’ Targets Nurse Practitioners Illegally Selling Opioids in Metro Detroit 12 May 2022 18:51 WJR - Michigan DETROIT, May 11, 2022 ~ Three women, two men, and three guns have been seized in an ongoing illegal prescription pill bust operation named “Operation Candy Man.” None of the detainees have been charged yet in connection to the crimes. According to …
- Opioid abuse treatments don't reach those most at risk 12 May 2022 12:18 Axios Data: CDC; Chart: Erin Davis/Axios Visuals Drugs for treating opioid abuse aren’t reaching most high-risk patients, potentially widening gaps in care as overdose deaths hit record highs. The big picture: New provisional data show a 15% surge in …
Follow Prescription Advisory
An improved PDMP … with accurate and timely data analysis should be regarded as the cornerstone of our collective efforts to address prescription drug abuse.
The AAOS recommends the following tools, which have been shown to significantly reduce medication errors:
- computerized physician order entry
- computerized decision support systems
- computerized monitoring of adverse drug events
- pharmacist-assisted rounds
- high-risk drug protocols
Overdose deaths are “just the tip of the iceberg”: that for every death there are many more hospital treatment admissions, emergency room visits, people who abuse or are dependent on prescription drugs and nonmedical users.
Attention to patterns of prescription requests and the prescribing of opioids as part of an ongoing relationship between a patient and a healthcare provider can decrease the risk of diversion. Periodic review of state PDMP, where available, is also a useful tool to monitor compliance. Evaluation should initially include…a drug history… Documentation is essential.
Prescribing or dispensing to an abuser, diverter, misuser or ‘doctor shopper’ puts the provider, their practice and or institution, as well as the patients at high risk.
Although relieving pain and reducing suffering are primary emergency physician responsibilities, there is a concurrent duty to limit the personal and societal harm that can result from prescription drug misuse and abuse.
You’re not only reducing the supply [of pain medications] for those who use them inappropriately, but also for those in need.
The AAOS recommends the following tools, which have been shown to significantly reduce medication errors:
- computerized physician order entry
- computerized decision support systems
- computerized monitoring of adverse drug events
- pharmacist-assisted rounds
- high-risk drug protocols
Overdose deaths are “just the tip of the iceberg”: that for every death there are many more hospital treatment admissions, emergency room visits, people who abuse or are dependent on prescription drugs and nonmedical users.
Use of a state PDMP may help identify patients who are at high risk for diversion or doctor shopping… To quantify the effects of PDMPs, studies were conducted of ED providers who cared for adult patients with pain. Of the patients with complete data in one study, information from the state’s PDMP System altered prescribing practice in 41%.
Prescription drug monitoring programs (PDMPs) are now active in most states to assist clinicians in identifying potential controlled drug misuse, diversion, or excessive prescribing. Little is still known about the ways in which they are incorporated into workflow and clinical decision making, what barriers continue to exist, and how clinicians are sharing PDMP results with their patients.
Design
Qualitative data were collected through online focus groups and telephone interviews.Setting
Clinicians from pain management, emergency and family medicine, psychiatry/behavioral health, rehabilitation medicine, internal medicine and dentistry participated.Patients
Thirty-five clinicians from nine states participated.Methods
We conducted two online focus groups and seven telephone interviews. A multidisciplinary team then used a grounded theory approach coupled with an immersion–crystallization strategy for identifying key themes in the resulting transcripts.Results
Some participants, mainly from pain clinics, reported checking the PDMP with every patient, every time. Others checked only for new patients, for new opioid prescriptions, or for patients for whom they suspected abuse. Participants described varied approaches to sharing PDMP information with patients, including openly discussing potential addiction or safety concerns, avoiding discussion altogether, and approaching discussion confrontationally. Participants described patient anger or denial as a common response and noted the role of patient satisfaction surveys as an influence on prescribing.Conclusion
Routines for accessing PDMP data and how clinicians respond to it vary widely. As PDMP use becomes more widespread, it will be important to understand what approaches are most effective for identifying and addressing unsafe medication use.
When a clinician is prescribing a controlled substance, readily available information about the drugs that a patient is receiving from other providers can be a critically important component of the decision-making process…Increasingly, these [PDMP] programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance.
Increasingly, these programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance Prescription Drug Monitoring Programs Serve a Vital Clinical Need.
Recommendations for full use of PDMP include:
- PDMPs can be effective clinical tools in medication management involving controlled substances.
- PDMPs should be available for clinicians across state boundaries.
- Every prescribing clinician should be familiar with the process of accessing and utilizing information from PDMP’s so that they can incorporate this information in their practices.
The AAOS recommends the following tools, which have been shown to significantly reduce medication errors:
- computerized physician order entry
- computerized decision support systems
- computerized monitoring of adverse drug events
- pharmacist-assisted rounds
- high-risk drug protocols
Overdose deaths are “just the tip of the iceberg”: that for every death there are many more hospital treatment admissions, emergency room visits, people who abuse or are dependent on prescription drugs and nonmedical users.
PDMPs have many limitations in their current format, including complex access issues, timeliness, and whether the data are presented to the physician automatically or require physician effort to retrieve.
Doctors (and other clinicians) need to know what prescriptions have been given to their patients by other practitioners. This information should be included in the patients’ electronic health care records accessible through a Prescription Drug Monitoring Program (PDMP) that provides immediate information.
The CDC advises providers to use PDMPs… States should consider ways to increase their use … available real-time, and alerts to prescribers.
An improved PDMP … with accurate and timely data analysis should be regarded as the cornerstone of our collective efforts to address prescription drug abuse.
Emergency Physicians must balance under-treatment of pain with concerns about drug diversion and doctor shopping. Use of a state PDMP may help identify patients who are at high risk for prescription opioid diversion or doctor shopping… To quantify the effects of PDMPs, studies were conducted of ED providers who cared for adult patients with pain. Of the patients with complete data in one study, information from the state’s PDMP System altered prescribing practice in 41%. Knowledge of the information provided had an important impact.
Thirteen multi-state PDMP projects were sponsored in 2012-13. While providers indicated that PDMPs gave them more confidence for prescribing pain medication, the study concluded that the easier the data is to obtain, the more they will be used, and the safer the practice can be.
Effective monitoring systems [PDMPs] will augment clinical judgment, provide evidence of misuse, and facilitate prescription of the most appropriate analgesic for the situation…The Emergency Department is regarded as the nation’s safety net…the last bastion of around-the-clock access to care … Unfortunately, some of the solutions to opioid misuse [limiting ED physicians to 3-day opioid prescriptions] preempts judgments from trained emergency medical providers.
Although relieving pain and reducing suffering are primary emergency physician responsibilities, there is a concurrent duty to limit the personal and societal harm that can result from prescription drug misuse and abuse.
When a clinician is prescribing a controlled substance, readily available information about the drugs that a patient is receiving from other providers can be a critically important component of the decision-making process…Increasingly, these [PDMP] programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance.
Increasingly, these programs have evolved into a useful tool for the clinician who must incorporate careful risk management into the prescribing of opioid analgesics or any other controlled substance Prescription Drug Monitoring Programs Serve a Vital Clinical Need.